Microsomal Triglyceride Transfer Protein Inhibitors [MoA] - N0000186778

Name: Table of NDC products with microsomal triglyceride transfer protein inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000186778
Pharmacologic Name	Microsomal Triglyceride Transfer Protein Inhibitors
Pharmacologic Uses	microsomal triglyceride transfer protein inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Microsomal Triglyceride Transfer Protein Inhibitors

The table contains 7 products whose active ingredient are classified under the same pharmacologic class Microsomal Triglyceride Transfer Protein Inhibitors [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
10122-402	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Chiesi Usa, Inc.	ACTIVE
10122-405	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Chiesi Usa, Inc.	ACTIVE
10122-410	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Chiesi Usa, Inc.	ACTIVE
10122-420	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Chiesi Usa, Inc.	ACTIVE
10122-430	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Chiesi Usa, Inc.	ACTIVE
76431-110	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Amryt Pharmaceuticals Dac	ACTIVE
76431-120	Juxtapid	Non-Proprietary Name: Lomitapide Mesylate	Capsule	Oral	Amryt Pharmaceuticals Dac	ACTIVE